Potassium supplement ameliorates salt-induced haemostatic abnormalities in normotensive subjects

Acta Cardiologica

Volumn 66, Issue 5, 2011, Pages 635-639

  Liu, Fuqiang ^a   Mu, Jianjun ^a   Yuan, Zuyi ^a   Zhang, Min ^a   Zheng, Shuhui ^a   Lian, Qiufang ^a   Liu, Enqi ^a,b   Xu, Haixia ^a   Ren, Keyu ^a   Huang, Qiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Dietary intervention; Haemostatic state; Potassium; Sodium

Indexed keywords

D DIMER; POTASSIUM; SODIUM CHLORIDE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; MALE; SODIUM RESTRICTION;

ADULT; ALGORITHMS; ANTIFIBRINOLYTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIET, SODIUM-RESTRICTED; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; REFERENCE VALUES; RURAL POPULATION; SODIUM CHLORIDE, DIETARY; VON WILLEBRAND FACTOR;

EID: 80053211990     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.5.2131090     Document Type: Article

References (26)

1. Muntzel M, Drüeke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5: 1S-42S.
2. He FJ, MacGregor GA. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 2007; 22: 298-305.
3. Cook NR. Salt intake, blood pressure and clinical outcomes. Curr Opin Nephrol Hypertens 2008; 17: 310-4.
4. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003; 17: 471-80.
5. Qin X, Jackson R, Marshall R, Lee LM, Cao WH, Zhan SY, Hu YH. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China. Eur J Cardiovasc Prev Rehabil 2009; 16: 96-101.
6. Mu J, Liu Z, Liu F, Xu X, Liang Y, Zhu D. Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents. Am J Hypertens 2009; 22: 943-7.
7. Umesawa M, Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr 2008; 88: 195-202.
8. Sasaki S, Zhang XH, Kesteloot H. Dietary sodium, potassium, saturated fat, alcohol, and stroke mortality. Stroke 1995; 26: 783-9.
9. Strazzullo PD, Lanfranco Kandala NC, Francesco P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339: b4567 (abstract).
10. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027-34.
11. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009; 169: 32-40.
12. Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006; 3: CD004641.
13. Perry IJ, Beevers DG. Salt intake and stroke: a possible direct effect. J Hum Hypertens 1992; 6: 23-5.
14. Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990; 15: 900-3.
15. du Cailar G, Mimran A. Non-pressure-related effects of dietary sodium. Curr Hypertens Rep 2009; 11: 12-7.
16. Lip GY, Blann AD, Edmunds E, Beevers DG. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension. Blood Coagul Fibrinolysis 2002; 13: 35-41.
17. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi DG, Venco A. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2008; 162: 2589-93.
18. Maresca G, Di BA, Marchioli R, Di MG. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999; 19: 1368-77.
19. Fang Y, Mu JJ, He LC, Wang SC, Liu ZQ. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive Asians. Hypertension 2006; 48: 724-9.
20. Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke 2004; 35: 1543-7.
21. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 1987; 316: 235-40.
22. Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK. Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke 2001; 32: 1473-80.
23. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288: 1882-8.
24. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004; 35: 1421-5.
25. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-5.
26. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 2008; 117: 1449-59.